Novel e-Lung CT biomarkers combine to provide higher prognostic discrimination than FVC in patients with non-IPF fibrotic interstitial lung disease - Milan 2023

Novel insights for the management of interstitial lung disease of known cause

Chair(s): Elena Bargagli, Kseniia Bielosludtseva

Session type: Oral presentation

Novel e-Lung CT biomarkers combine to provide higher prognostic discrimination than FVC in patients with non-IPF fibrotic interstitial lung disease

Peter George

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - A pilot study of telemonitoring to detect acute exacerbations in fibrosing interstitial lung diseases

Yuanyuan Jia

Replay

Poster

Abstract

The automated e-Lung CT algorithm is more prognostic than lung function in patients with non IPF fibrotic ILD; a validation study

Peter George

Replay

Abstract

Slides

Dendritic cells as a potential new tool in predicting patient's survival in airway-centered interstitial fibrosis

Mateus Magalhaes Lage Moraes

Replay

Poster

Abstract

Slides

Electronic nose technology detects connective tissue disease-associated interstitial lung disease

Karen Moor

Replay

Poster

Abstract

Slides

AI-based quantification of ILD and pulmonary vasculature in a retrospective SSc-ILD cohort correlates with pulmonary function test: a perspective from the PROFILE.net ERS Clinical Research Collaboration

Julien Guiot

Replay

Poster

Abstract

Slides

Unveiling common molecular pathways linked to ILDs with progressive fibrosing phenotype: the role of MUC5B promoter variants

Helder Novais Bastos

Replay

Poster

Abstract

Slides

Novel e-Lung CT biomarkers combine to provide higher prognostic discrimination than FVC in patients with non-IPF fibrotic interstitial lung disease

Peter George

Replay

Abstract

Slides

Skin transcriptomes link severity of skin involvement and lung function impairment in systemic sclerosis

Jana Zielonka

Replay

Poster

Abstract

Slides

Progression of interstitial lung disease in systemic sclerosis does not predict further progression

Anna Maria Hoffmann-vold

Replay

Poster

Abstract

Slides

Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study

Joshua Solomon

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}